Variant Boosters, Bivalent and Polyvalent Vaccines… Who’s Going to Break the Stalemate with COVID-19?
ACROBiosystems announces the release of their latest BA.2.75 antigen products
Newly launched——Useful Tools for Nucleic Acid Contamination Removal
The Key Role of ACROBiosystems in CGT Development
ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
This web search service is supported by Google Inc.